Hippocampal Glutamate and Positive Symptom Severity in Clinical High Risk for Psychosis

Basavaraju, R., Guo, J., Small, S. A., Lieberman, J. A., Girgis, R. R., & Provenzano, F. A. (2022). Hippocampal Glutamate and Positive Symptom Severity in Clinical High Risk for Psychosis. JAMA Psychiatry, 79(2), 178. https://doi.org/10.1001/jamapsychiatry.2021.3710
Authors:
Rakshathi Basavaraju
Jia Guo
Scott A Small
Jeffrey A Lieberman
Ragy R Girgis
Frank A Provenzano
Affiliated Authors:
Rakshathi Basavaraju
Jia Guo
Scott A Small
Jeffrey A Lieberman
Ragy R Girgis
Frank A Provenzano
Columbia Affiliation:
Subjects:
Glutamic Acid (MeSH)
Hippocampus (MeSH)
Psychotic Disorders (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1001/jamapsychiatry.2021.3710
PMID:
34964821
DOI:
10.1001/jamapsychiatry.2021.3710
Journal:
JAMA Psychiatry
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: